Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $48.5330 (-0.93%) ($46.8555 - $48.9703) on Mon. Feb. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.3% (three month average) | RSI | 55 | Latest Price | $48.5330(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.5% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) SPY(47%) IBB(46%) | Factors Impacting ABBV price | ABBV will decline at least -1.15% in a week (0% probabilities). VIXM(-20%) TLT(-14%) UUP(-10%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.15% (StdDev 2.3%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $50.05 | 5 Day Moving Average | $50.06(-3.05%) | 10 Day Moving Average | $50.69(-4.26%) | 20 Day Moving Average | $50.05(-3.03%) | To recent high | -14.3% | To recent low | 6.3% | Market Cap | $85.626b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |